Active, not recruitingNot applicableNCT01892397
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
Studying Meningioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Thomas Kaley, MD, MD, PHDMemorial Sloan Kettering Cancer Center
- Intervention
- Optune (NovoTTF-100A)(device)
- Enrollment
- 6 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2026
Study locations (9)
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- University of Colorado, Denver, Colorado, United States
- University of Miami, Miami, Florida, United States
- Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center at Commack, Commack, New York, United States
- Memorial Sloan Kettering West Harrison, Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Columbia University, New York, New York, United States
- University of Cincinnati, Cincinnati, Ohio, United States
Collaborators
NovoCure Ltd. · Columbia University · University of Cincinnati · University of Colorado, Denver · University of Miami · Cedars-Sinai Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01892397 on ClinicalTrials.govOther trials for Meningioma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07413796Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted SuturesMedical University of Warsaw
- RECRUITINGPHASE2NCT06955169Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior TreatmentRTOG Foundation, Inc.
- RECRUITINGPHASE1, PHASE2NCT07150806RYZ101 for the Treatment of Progressive or Recurrent Intracranial MeningiomaJoshua Palmer
- RECRUITINGNANCT06831461Proton Versus Photon Radiotherapy in Adults With Primary Brain TumorsTata Memorial Centre
- RECRUITINGNCT07044076Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With MeningiomasCentre Hospitalier St Anne
- RECRUITINGPHASE2NCT05940493Abemaciclib in Newly Diagnosed Meningioma PatientsNader Sanai
- RECRUITINGNCT06874426The Impact of Endoscopic Endonasal Skull Base Surgery on OlfactionUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGPHASE2NCT06326190177Lu-DOTATATE for Recurrent MeningiomaEuropean Organisation for Research and Treatment of Cancer - EORTC